Clinical Trial Update: Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial at the University of Chicago is evaluating a personalized, adaptive treatment approach for locally advanced head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University of Chicago | Conditions: HPV-Negative Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING